Fredun Pharmaceuticals Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹228.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.13 per cent from ₹213.05 crore. This corresponds to a year-on-year *(YoY) growth of 90.45 per cent.
Operating Profit
Operating Profit stands at ₹32.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.37 per cent from ₹28.88 crore. This corresponds to a year-on-year *(YoY) growth of 92.70 per cent.
PBDT
PBDT stands at ₹24.12 crore, reflecting a quarter-on-quarter *(QoQ) increase of 67.50 per cent from ₹14.40 crore. This corresponds to a year-on-year *(YoY) growth of 130.59 per cent.
Profit Before Tax
Profit Before Tax stands at ₹20.55 crore, reflecting a quarter-on-quarter *(QoQ) increase of 82.67 per cent from ₹11.25 crore. This corresponds to a year-on-year *(YoY) growth of 127.32 per cent.
Net Profit
Net Profit stands at ₹13.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.80 per cent from ₹10.78 crore. This represents a 93.94 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Fredun Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Fredun Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Fredun Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Fredun Pharmaceuticals Ltd Financial Reports
Fredun Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Fredun Pharma | 0.79% | 13.00% | 36.62% | 49.23% | 99.84% | 258.31% |
| Panacea Biotec | -0.07% | -1.44% | -23.72% | 8.31% | 16.40% | 5.36% |
| Solara Active | 4.42% | 0.79% | -10.44% | -0.53% | 7.43% | -11.67% |
| NGL Fine Chem | 0.78% | 4.92% | 9.32% | 52.91% | 54.10% | 183.93% |
| Ind-Swift Labs. | 3.30% | 2.36% | -0.99% | 70.46% | 77.58% | 127.80% |
| Hester Bios | -0.33% | -2.59% | -4.75% | 38.64% | 57.62% | 24.89% |
| Indoco Remedies | -0.54% | -1.34% | -15.03% | 0.46% | 7.54% | -22.52% |
Company Info
Company Information
Chairman / Executive Director / Joint MD : Daulat N Medhora
Executive Director / Managing Director / CFO : Fredun N Medhora
Independent Non Exe. Director : Daisy Dsouza
Independent Non Exe. Director : Anshu Agarwal
Independent Non Exe. Director : Sonal Desai
Independent Non Exe. Director : Pooja Narendra Sanghavi
Company Sec. & Compli. Officer : Vaishnavi Rajkamal Sahu